Treatment with plasma exchange of a pregnant woman with anti-PP1Pk alloimmunization: A case report.

The histo-blood group antigens P, P1 and Pk are a closely related set of glycosphingolipid structures expressed by red blood cells and other tissues. None of these three characters is expressed on p cells, a null phenotype that arises in the context of homozygous mutation of the A4GALT gene. Subjects with p phenotype spontaneously develop a natural alloantibody named anti-PP1Pk, which is a mixture of IgG and IgM against P1, P and Pk. While anti-P1 is a weak cold antibody with poor clinical significance, anti-P and anti-Pk antibodies are potent haemolysins responsible for severe hemolytic transfusion reactions. The rare anti-PP1Pk alloantibodies are associated with recurrent spontaneous abortion in the first trimester of gestation. P and Pk antigens are expressed at high levels on the placenta and antibodies directed against both these structures are deleterious to placental trophoblasts. Here we describe the use of plasma exchange (PEX) in a nulliparous 39-year-old woman with anti-PP1Pk antibodies and a history of repeated spontaneous early abortions and hypofertility. The patient underwent apheresis starting from the third week throughout the pregnancy and a healthy child was delivered by cesarean section at 35 WG. The newborn required only phototherapy within a few days of life. We can state that an early treatment with the only PEX has proven to be effective and safe in the management of a fetomaternal P-incompatibility caused by a high anti-PP1Pk titer (256).

[Intrahepatic cholestasis in pregnancy and perinatal risk]. / La colestasia intrahepática del embarazo y el riesgo perinatal.

The main purpose of this study was to analyze the accuracy of severity criteria applied in cholestatic jaundice in pregnancy related to health problems in the newborn. The sample, 209 cases, is formed by the total of hospital patients discharges from the Pathologic Pregnancy Unit. Severe cholestatic jaundice (59.3% of cases) presented early itching and impeding premature delivery as the most frequent severity criteria. We found that the greater number of severity criteria, the worse prognosis for the newborn, as shown by birth weight under 2,500 g and Apgar at the minute of 7 or less. Both differences were statistically significant (p = 0.0001; p = 0.0348). No maternal or perinatal deaths were found. Our conclusions are: 1. Severity criteria used in cholestatic jaundice of pregnancy are valied and 2. Clinical management of cases is appropriate, since the major risk reported (perinatal mortality) was absent and maternal and perinatal morbidity were less than those reported in previous studies.